UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy for unresectable liver cancer shows promise in early trial
Disease control Recruiting nowThis study is for people with advanced liver cancer that cannot be removed by surgery. It tests a treatment that uses the patient's own immune cells, trained in a lab to attack the tumor, combined with immunotherapy drugs and a pneumonia vaccine, all given after high-dose radiati…
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
Promising combo therapy for incurable bile duct cancer enters human trials
Disease control Recruiting nowThis early-stage trial tests whether combining a targeted liver radiation procedure (Y90 radioembolization) with two immunotherapy drugs (durvalumab and tremelimumab) is safe and shows promise for people with bile duct cancer that cannot be surgically removed. The study enrolls 1…
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:04 UTC